19 Nov 2013, BioSpectrum Bureau , BioSpectrum
Singapore: Merck has decided to stop production of active ingredient at one of its plants in Puerto Rico, in what is been seen as a blow to a city that was once considered a pharmaceutical hub.
The company will stop production in Barceloneta by late 2014 as part of a global restructuring. Merck said formulation and packaging operations at that plant will continue under a third-party contract.
The company will also consolidate formulation operations at its plant in Arecibo with another plant in the eastern city of Las Piedras, where it has invested more than $100 million in recent years to launch three new products.
Mr Cesar Simich, managing director, Merck, Puerto Rico and the Caribbean, said that he doesn't yet know how many people would lose their jobs as a result of the restructuring